These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33743630)

  • 21. COVID-19 imported cases and severity: expected information from genomic characterization of SARS-CoV-2 strains in Mozambique.
    Sumbana J; Passanduca A; Rubino S
    J Infect Dev Ctries; 2021 Dec; 15(12):1792-1800. PubMed ID: 35044934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the emergency response strategies and measures on the epidemic of COVID-19 in Shenzhen, China].
    Zou X; Wu YS; Liu XJ; Huang SL; He JF; Zhao J; Wu N; Zhang RL; Mei SJ; Liu PY; Zhang Z; Shi XL; Lyu X; Wei L; Ma QS; Lu JH; Li Y; Feng TJ; Peng CQ; Zhang SX; Xia JJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Aug; 41(8):1225-1230. PubMed ID: 32340094
    [No Abstract]   [Full Text] [Related]  

  • 23. Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel.
    Dickens BL; Koo JR; Lim JT; Sun H; Clapham HE; Wilder-Smith A; Cook AR
    J Travel Med; 2020 Dec; 27(8):. PubMed ID: 32841354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of the COVID-19 in Iraq - Implications for travellers.
    Al-Malkey MK; Al-Sammak MA
    Travel Med Infect Dis; 2020; 38():101739. PubMed ID: 32405265
    [No Abstract]   [Full Text] [Related]  

  • 25. The impact of re-opening the international border on COVID-19 hospitalisations in Australia: a modelling study.
    Hanly MJ; Churches T; Fitzgerald O; Post JJ; MacIntyre CR; Jorm L
    Med J Aust; 2022 Jan; 216(1):39-42. PubMed ID: 34633100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The first laboratory-confirmed imported infections of SARS-CoV-2 in Sudan.
    Aljak ER; Eldigail M; Mahmoud I; Elhassan RM; Elduma A; Ibrahim AA; Ali Y; Weaver SC; Ahmed A
    Trans R Soc Trop Med Hyg; 2021 Jan; 115(1):103-109. PubMed ID: 33319246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and Control Measures for Imported SARS-CoV-2 Transmission During the Postpandemic Period in Shenzhen, China.
    He X; Gong F; Sun X; Hu G; Lin J
    Disaster Med Public Health Prep; 2022 Mar; 17():e143. PubMed ID: 35241200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating the COVID-19 risk during the Hajj pilgrimage.
    Khan A; Bieh KL; El-Ganainy A; Ghallab S; Assiri A; Jokhdar H
    J Travel Med; 2020 Dec; 27(8):. PubMed ID: 32889536
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interval between entry of mainland China and diagnosis in imported COVID-19 cases and factors contributing to delayed diagnosis in Guangdong Province].
    Cheng L; Xu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):741-745. PubMed ID: 32897209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of overseas imported malaria situation and implication for control in Jiangsu Province, PR China].
    Liu YB; Cao J; Zhou HY; Wang WM; Cao YY; Gao Q
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Feb; 25(1):44-7. PubMed ID: 23687811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission.
    Aggarwal D; Page AJ; Schaefer U; Savva GM; Myers R; Volz E; Ellaby N; Platt S; Groves N; Gallagher E; Tumelty NM; Le Viet T; Hughes GJ; Chen C; Turner C; Logan S; Harrison A; ; Peacock SJ; Chand M; Harrison EM
    Nat Commun; 2022 Feb; 13(1):1012. PubMed ID: 35197443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020.
    Wang Y; Yu J; Wang F; Zhang Y; Ma S
    Front Public Health; 2023; 11():1151038. PubMed ID: 37089485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiologic Trends and Distributions of Imported Infectious Diseases Among Travelers to Japan Before and During the COVID-19 Pandemic, 2016 to 2021: A Descriptive Study.
    Kasamatsu A; Kanou K; Fukusumi M; Arima Y; Omori S; Nakamura H; Sato T; Serizawa Y; Takeda A; Fujikura H; Ikenoue C; Nishiki S; Fujiya Y; Arashiro T; Takahashi T; Shimada T; Suzuki M; Sunagawa T
    J Epidemiol; 2024 Apr; 34(4):187-194. PubMed ID: 37331795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantifying COVID-19 importation risk in a dynamic network of domestic cities and international countries.
    Han X; Xu Y; Fan L; Huang Y; Xu M; Gao S
    Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34285082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantifying the improvement in confirmation efficiency of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early phase of the outbreak in Hong Kong in 2020.
    Ran J; Zhao S; Zhuang Z; Chong MKC; Cai Y; Cao P; Wang K; Lou Y; Wang W; Gao D; Yang L; He D; Wang MH
    Int J Infect Dis; 2020 Jul; 96():284-287. PubMed ID: 32413609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the effectiveness of measures to control the novel coronavirus disease 2019 in Jilin Province, China.
    Zhao Q; Wang Y; Yang M; Li M; Zhao Z; Lu X; Shen B; Luan B; Zhao Y; Cao B; Yao L; Zhao B; Su Y; Chen T
    BMC Infect Dis; 2021 Mar; 21(1):245. PubMed ID: 33676420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of COVID-19 in Australia through quarantine: the role of special health accommodation (SHA) in New South Wales, Australia.
    Fotheringham P; Anderson T; Shaw M; Jewitt J; Storey H; Hutchings O; Cartwright J; Gupta L
    BMC Public Health; 2021 Jan; 21(1):225. PubMed ID: 33504347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.